ENTITY
Hyphens Pharma International

Hyphens Pharma International (HYP SP)

29
Analysis
Health CareSingapore
Hyphens Pharma International Limited is Singapore’s leading specialty pharmaceutical and consumer healthcare group. It develops and owns several dermatological products and supplements, such as Ceradan, TDF and Ocean Health. The Group also markets and sells specialty pharmaceutical products through exclusive agreements, as well as operates an online B2B platform for healthcare professionals. Please visit us at https://www.hyphensgroup.com for more information.
more
Refresh
31 Aug 2020 08:00Exchange-sponsored

Non-SGX Report: Hyphens Pharma International Limited: Broadening Product Range and Footprints

These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external contributors....

Share
24 Aug 2020 08:00Exchange-sponsored

Non-SGX Report: Hyphens Pharma Intl Ltd: A Hair-Raising First Half

These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external contributors....

Share
22 Nov 2019 08:00Exchange-sponsored

Non-SGX Report: Hyphens Pharma International Limited: 3Q2019 Net Profit Surged 51.5%

These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external contributors. Please...

Share
22 Nov 2019 08:00Exchange-sponsored

Non-SGX Report: Hyphens Pharma International Limited: 3Q2019 Net Profit Surged 51.5%

These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external contributors. Please...

Share
08 Nov 2019 08:00Exchange-sponsored

Non-SGX Report: Hyphens Pharma International Limited: Healthy Prospects in ASEAN

These equity research reports are not written by the SGX. SGX supports the distribution of the research reports by external contributors. Please...

Share
x